Viyash Scientific Limited

Nature of Disclosure: Regulatory filing regarding the allotment of equity shares pursuant to employee stock option plans.

Key Quantitative Figures:

  • Total equity shares allotted: 67,893 shares of face value ₹2 each
  • Under Sequent ESOP 2020: 25,600 shares at exercise price of ₹86 per share
  • Under Viyash ESOP 2026: 42,293 shares at exercise price of ₹101 per share
  • Pre-allotment paid-up capital: ₹88,39,83,916 (44,19,91,958 equity shares)
  • Post-allotment paid-up capital: ₹88,41,19,702 (44,20,59,851 equity shares)
  • Capital increase: ₹1,35,786

Dates of Action:

  • Nomination and Remuneration Committee approval: November 19, 2026 (via circulation)

Parties Involved:

  • Viyash Scientific Limited (formerly Sequent Scientific Limited)
  • Nomination and Remuneration Committee
  • Eligible optionees under two ESOP schemes

Regulatory References: Implied regulatory disclosure requirement for material corporate actions.

Capital Structure Impact:

  • Increase in issued share capital from 44,19,91,958 to 44,20,59,851 equity shares
  • Minimal dilution effect of approximately 0.15%
  • New shares rank pari passu with existing equity shares

Cash Flow Implications:

  • Cash inflow to company from exercise prices: ₹25,600 × ₹86 = ₹22,01,600 from Sequent ESOP 2020; ₹42,293 × ₹101 = ₹42,71,593 from Viyash ESOP 2026; Total inflow: ₹64,73,193

The allotment represents routine ESOP exercise activity with minimal impact on overall capital structure.